QUVIVIQ 25 mg film-coated tablets

Licence status
Authorised: 29/04/2022
Active substances
Daridorexant hydrochloride
Dosage Form
Film-coated tablet
Licence number
EU/1/22/1638/001-002
Licence holder
Idorsia Pharmaceuticals Deutschland GmbH

Product documents

Licence information

ATC code
N05CJ03 daridorexant
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
29/04/2022